USBiomax provides of human tissue array or tissue microarray and their related products. USBiomax has established a comprehensive and integrated system to collect various normal and diseased human tissues, and continuing throughout the manufacturing process of hundreds of tissue microarrays. By offering various high-quality tissue arrays in a format of single, paired, combined and multiple panels, USBiomax enables scientists to identify, verify and validate molecules of diagnostic and therapeutic importance. With DNA (gene) array technique, tissue microarray technology is a powerful tool for the rapid analysis of molecular targets, discovery and assessment of new therapeutics, and determining prognosis of a disease.
USBiomax's tissue repository contains more than 600,000 paraffin tissue blocks and a large selection of tissue section slides. We also provide tissue microarray OEM services. Please contact email@example.com for further information.
USBiomax has developed more than 160 types of human tissue arrays including not only common tumors, such as colon cancer, prostate cancer, breast cancer, cervical cancer, ovarian cancer, lung cancer, stomach cancers, esophageal cancer, rectum cancer, kidney and liver cancer, etc., but also rare types of malignancies, e.g. brain glioma (neuroblastoma), lymphoma, osteosarcoma, condrasarcoma (cartilage sarcoma), bladder cancer, thyroid cancer, spongioblast tumor and lung small cell carcinoma. We also manufacture common types of normal multiple organs of tissue arrays.
USBiomax also provides services in Immunohistochemistry (IHC) staining and in situ hybridization (ISH) to localize the protein/gene of interest by using customer-supplied antibodies, DNA fragments or oligonucleotides on normal and diseased human tissues selected from USBiomax's tissue array bank. These services are highly cost-effective and conducted to the highest standards to assist you in understanding function of your genes/proteins or in identification and validation of your potential diagnostic and therapeutic targets. The results are presented as a publishable, detailed pathology report accompanied by high-resolution digital photographs